The head of a top Brazilian health research institute says its scientists have discovered the Zika virus in urine and saliva.» Read More
If successful, Moderna Therapeutics' cutting-edge drug method could be used to fight cancer and some infectious diseases.
This company has raised $1 billion to develop the Holy Grail in drugs: Have the body's own cells churn out proteins to fight disease.
Mary Wittenberg of NYRR will join Virgin Sport, a branch of Virgin Group that aims to grow participation in running and cycling events.
The Obama administration reminded insurers that women can get birth control covered without out-of-pocket fees.
Britain's GlaxoSmithKline is to collaborate with U.S. scientists in developing a cure for AIDS.
The most expensive 5 percent of Medicaid-only enrollees accounted for nearly half of all spending on such enrollees in each year from 2009 through 2011.
A damning 2009 New Yorker article was followed by "unprecedented" savings on Medicare costs in a Texas town.
A development in how patient requests for experimental drugs are handled could be a big step in health care, said a medical director Thursday.
A ferocious winter, delayed spring and climate change have created a "pollen tsunami" in the Northeast, NBC News reports.
Millennials are twice as likely to challenge the cost of their medical care than the general population, and that could have a big impact on your health care.
Diabetics have three times the health costs of non-diabetics, and the cost to treat diabetic kids is rising rapidly.
Managing tight spaces isn't new for dentists, but fitting into a tiny office requires some creativity, and a lot of technology.
Figuring out how much to save for future health-care costs is one of the toughest parts of retirement planning. Here's what you should know.
Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests.
Employment health plans were the big engine for covering people after Obamacare launched, with 9.6 million newly insured.
In a world where you can order what you want at a click of a button; shouldn't technology help you watch what you eat?
Unless Europe’s governments take action, it will be dealing with an obesity epidemic of vast proportions by 2030, according to new projections.
Alexion said it would buy Synageva for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.
One of the U.K's most prominent fund managers has joined Bill Gates in backing a small biopharmaceutical firm with a bumper $50 million investment.
The U.S. government said health insurers must cover all FDA-approved methods of birth control without co-pays or charges to the patient.
Get the best of CNBC in your inbox